MBBS Interns May Take Ayush Training As An Elective, Says NMC

MUMBAI : MBBS students will soon have to undergo internship training in Ayush, along with their other postings.

A draft regulation for Compulsory Rotating Internship, 2021, released by the National Medical Commission (NMC), mentioned that a week’s training should be included in the rotational schedule in any of the Indian systems of medicine as an elective. In a welcome move, a week’s training each in any two super specialty disciplines, including cardiology, nephrology, pulmonary medicine, and medical oncology, has been included in the internship for MBBS students.

Of the 17 postings which MBBS students have to complete over a period of 12 months after graduation, 14 are mandatory and three are electives. The training in super specialty disciplines and Indian systems of medicine are among the electives. For Ayush, the NMC mentioned that interns can choose any elective from ayurveda, yoga, unani, homeopathy and Siddha Sowa Rigpa.

Sudha Shenoy, a parent representative, said internships are usually done in students’ own specialty. “This will also reduce their time spent in specialties they are expected to be trained in,” she added.

A doctor from a civic hospital said: “They should be aware of Ayush, but we hope the training will be on awareness only. There was perhaps no need to include it explicitly in the regulations,” he said. Including super specialty training in internship will give better exposure, said an intern from a government hospital.

The NMC has also recommended that students complete their internship from the same institute they graduate from, leaving no scope for transfers. Many seek transfer from private colleges to government ones for better exposure.

  • Related Posts

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

    FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch